GIORGIONI, Gianfabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.394
EU - Europa 2.862
AS - Asia 1.497
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 5
OC - Oceania 5
Totale 11.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.155
CN - Cina 1.127
IT - Italia 758
DE - Germania 534
UA - Ucraina 283
SE - Svezia 275
PL - Polonia 242
GB - Regno Unito 236
CA - Canada 233
SG - Singapore 196
FI - Finlandia 179
FR - Francia 110
TR - Turchia 99
IE - Irlanda 79
CZ - Repubblica Ceca 49
BE - Belgio 40
NL - Olanda 25
RU - Federazione Russa 17
EU - Europa 13
IN - India 12
IR - Iran 12
VN - Vietnam 11
KR - Corea 9
PE - Perù 8
PK - Pakistan 7
MX - Messico 6
BR - Brasile 5
GR - Grecia 5
PT - Portogallo 5
RO - Romania 5
AU - Australia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
HK - Hong Kong 3
JP - Giappone 3
AR - Argentina 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
GE - Georgia 2
HU - Ungheria 2
NO - Norvegia 2
TH - Thailandia 2
UY - Uruguay 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
LT - Lituania 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 11.798
Salva come PNG Salva come JPEG
Città #
Fairfield 768
Woodbridge 754
Jacksonville 700
Chandler 534
Ann Arbor 445
Ashburn 444
Houston 435
Wilmington 375
Boardman 335
Seattle 315
Cambridge 287
Nanjing 234
Camerino 168
Toronto 166
Warsaw 147
Singapore 141
San Mateo 121
Dearborn 106
Lawrence 100
Princeton 100
Helsinki 92
Kraków 91
Istanbul 85
Beijing 82
Nanchang 82
Ogden 82
Columbus 78
Dublin 77
Shenyang 69
Lachine 63
Kunming 56
Shanghai 54
Redwood City 50
London 48
Düsseldorf 47
Hebei 42
Tianjin 42
Munich 41
Los Angeles 39
Brno 38
Brussels 38
New York 32
Jiaxing 30
San Diego 29
Guangzhou 28
Milan 28
Wuhan 26
Changsha 25
Jinan 25
Bremen 24
Centro 22
Philadelphia 22
Leawood 21
Ningbo 20
Venezia 19
Augusta 18
Hangzhou 17
Hefei 17
Venice 17
Auburn Hills 16
Orange 15
Chicago 14
Nürnberg 14
Zhengzhou 14
Monmouth Junction 13
Taizhou 13
Kocaeli 12
Dronten 10
Norwalk 10
Ardabil 9
Changchun 9
Dong Ket 9
Olomouc 9
Verona 9
Lima 8
Rome 8
Strasbourg 8
Washington 8
Falls Church 7
Fermo 7
Jinhua 7
Lahore 7
Lanzhou 7
Shenzhen 7
Chongqing 6
Council Bluffs 6
Fabriano 6
Hanover 6
Perugia 6
Pesaro 6
Senigallia 6
Seoul 6
Yiwu 6
Ascoli Piceno 5
Bergamo 5
Berlin 5
Buffalo 5
Espoo 5
Frankfurt am Main 5
Portland 5
Totale 8.730
Salva come PNG Salva come JPEG
Nome #
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 267
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 249
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 234
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 208
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 205
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 193
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 185
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 185
Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process 173
Evaluation of methoxy polyethylene glycol-polylactide diblock copolymers as additive in hypromellose film coating 169
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 168
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 165
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 160
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 157
Monitoring the aggregation behaviour of self-assembling polymers through high-resolution ultrasonic spectroscopy, 156
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 156
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 154
Synthesis and Preliminary Pharmacological Evaluation of 5-Hydroxy- and 5,6-Dihydroxy-1,2,3,7,12,12a-hexahydrobenzo [5,6]cyclohepta[1,2,3-ij]isoquinoline Derivatives as Dopamine Receptor Ligands 151
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno [2,3,4-de]isoquinolines 150
Novel Imidazoline Compounds as Partial or Full Agonists of D2-Like Dopamine Receptors Inspired by I2-Imidazoline Binding Sites Ligand 2-BFI 149
Thermosensitive self-assembling block copolymers as drug delivery systems 149
Glycosyl and polyalcoholic prodrugs of lonidamine. 148
Synthesis and Evaluation of 2-(5-Methoxythiophen-3- yl)ethylamines as Potential Dopamine Agonists 147
Dopamine D-5 receptors: A challenge to medicinal chemists 147
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 147
Evaluation of polymer mucoadhesiveness by the use of acoustic spectroscopy 146
New 2- pyridylethylamines with dopaminergic activity: synthesis and radioligand binding evaluation 145
Dimeric L-Dopa Derivatives as Potential Prodrugs 144
Evaluation of 2,3,4,8,13a hexahydro-1H-benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 143
Synthesis and Pharmacological Characterization of 2-(4-Chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl Derivatives as Dopamine Receptor Ligands 142
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D-1 receptor full agonist 142
Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-Dopa 142
3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-5,6,7,8-tetrahydro-4(3H)quinazolinones: serotonin 5-HT2A receptor antagonists endowed with potent, central action 140
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 140
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 139
Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands 138
New L-dopa codrugs as potential antiparkinson agents 137
New Systems for the Specific Delivery and Sustained Release of Dopamine to the Brain 137
Correlation among chemical structure, surface properties and cytotoxicity of N-acyl alanine and serine surfactants 137
4-(3-Piridil)-1,2,3,4-tetraidroisochinoline potenziali ligandi dei recettori della dopamina 136
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 135
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 133
Synthesis, resolution and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptor ligands 133
Receptors in aging diseases: Dopamine receptors 132
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 131
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 130
Quaternary Ammonium Leucine-Based Surfactants: The Effect of a Benzyl Group on Physicochemical Properties and Antimicrobial Activity 129
Synthesis and Biological Evaluation of GABA Derivatives Able to Cross the Blood -Brain Barrier in Rats 128
Design, synthesis and preliminary pharmacological evaluation of new imidazolinonesas L-DOPA prodrugs 128
Quaternary ammonium surfactants derived from leucine and methionine: Novel challenging surface active molecules with antimicrobial activity 126
Chemical–physical properties and cytotoxicity of N-decanoyl amino acid-based surfactants: Effect of polar heads 121
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 115
5HT2B receptor antagonists: a probe for spotting the pharmacophore 114
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 110
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 109
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 109
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 107
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 107
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinoles as dopamine receptor ligands 105
Novel Dopamine Receptor Ligands Bearing Imidazoline Nucleus. 105
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 103
4-Aryloxy-1,2,3,4-tetrahydroisoquinolines as new potential antipsychotic drugs 100
Preparation and Pharmacological Characterization of trans-2-Amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like Dopamine Receptor Agonists 100
Synthesis and Evaluation of N-n-Propyl-N-(2-phenylethyl)-2-(3-fluoro-4- hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 99
Imidazolidinoni profarmaci della L-DOPA 97
Activity of N-(2-Phenylethyl)-N-n-Propyl-2-(3-Hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 96
Synthesis and SAR of group 11 N-heterocyclic carbene complexes 96
Toxicological profiles and surface properties at physiological pH of N-decanoyl amino acids 96
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 93
DISCOVERY OF NEW POTENTIAL gamma-SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 91
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 91
A Comparative Behavioural Analysis in Rats of the D2 Agonist RU 24213 and Two New Structurally Similar Compounds 90
L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents 90
Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or cognitive and memory performances impaired by scopolamine treatment orlesions of the nucleus basalis of Meynert 89
4WD to Travel Inside the 5-HT1A Receptor World 88
Receptors in aging disease 87
A de novo design probe of a dopamine receptor ligand based on a theoretical approach 86
Polyhydroxylic Prodrugs of Lonidamine 85
Synthesis and Dopamine Receptor Binding of 4-(2-Aminoethyl)-1H-pyrazole and Its N,N- Dialkyl Derivatives 83
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives 82
Structure-Activity Relationships of N-n-Propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 82
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 82
REMEMBERING MARIA PIGINI AND HER TWO DECADES OF IMIDAZOLINES 69
Trends in drug Research 68
Medicinal chemistry and pharmacology of purinergic receptors 68
NOVEL TETRAHYDRODIBENZOOXAAZECINES AS A PROBE TO DISCRIMINATE DOPAMINE D1/D5 RECEPTORS 65
IBUPROFEN AND LIPOIC ACID DIAMIDE AS CO-DRUGS WITH NEUROPROTECTIVE ACTIVITY: PHARMACOLOGICAL PROPERTIES AND EFFECTS IN Βeta-AMYLOID (1-40) INFUSED ALZHEIMER’S DISEASE RAT MODEL 64
ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO THE SEROTONIN 5-HT1A RECEPTOR 63
Futuro in Ricerca 2013 58
Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus 57
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 54
New anticancer copper complexes containing ligands conjugated with biologically active molecules 52
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 49
Novel antitumor Cu(I) and Cu(II) complexes based on bioconjugate ligands rationally designed to act through synergistic mechanisms 46
Effect on binge eating episode in female rats of a potent 1 antagonist analogue of spipethiane 44
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma 38
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects 33
Underlying susceptibility to eating disorders and drug abuse: Genetic and pharmacological aspects of dopamine D4 receptors 31
Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases 30
Copper complexes with adamantane ring-conjugated ligands as promising agents for the treatment of glioblastoma 27
Totale 11.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.299 0 0 0 0 118 234 207 228 170 134 65 143
2020/20212.003 100 179 164 161 119 140 282 56 155 95 380 172
2021/20221.052 83 262 18 51 84 57 35 73 86 117 56 130
2022/20231.484 180 49 75 194 163 201 17 90 264 79 122 50
2023/20241.084 127 61 100 34 39 93 57 36 118 35 24 360
2024/2025820 167 90 321 165 77 0 0 0 0 0 0 0
Totale 12.030